Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

Presentation TCT 2017

Flash Debate on Calcium Management: The Case for Orbital Atherectomy in Most Cases!

Presenter: Alaide Chieffo, Jonathan M. Hill, Michael S. Lee

October 31, 2017

News Conference News TCT 2016

RIBS VI: El SVB Absorb es Seguro en el Manejo de la Reestenosis Intra-stent pero No Supera al Stent Metálico Xience

Michael O'Riordan

November 08, 2016

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

News Conference News TCT 2016

RIBS VI：Absorb BVS 支架内再狭窄方面安全，但没有好过 Xience 金属支架

Michael O'Riordan

November 08, 2016

News Conference News TCT 2016

TRANSFORM-OCT: 生物可吸收和耐久聚合物 DES 早期和晚期愈合率类似

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

Michael O'Riordan

November 02, 2016

Presentation TCT 2016

The Tricuspid Valve: Challenges for Clinical Investigation

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies

Presenter: Matthew G. Hillebrenner, Michael J. Mack, John C Laschinger

November 01, 2016

Presentation TCT 2014

Are the Current Clinical Trial Pathways for New Mitral Valve Therapies Practical? A Future Roadmap to Consider!

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Francesco Maisano, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Mitral Valve Repair vs Replacement: Complementary or Competitive?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Francesco Maisano

September 16, 2014

Presentation TCT 2014

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia

September 16, 2014

Presentation TCT 2014

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim

September 16, 2014

Presentation TCT 2014

A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Martin B. Leon

September 16, 2014

Presentation TCT 2014

Clinical Indications for TAVR: Where are We and Where are We Going?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, A. Pieter Kappetein

September 16, 2014

Advertisement

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Flash Debate on Calcium Management: The Case for Orbital Atherectomy in Most Cases!

RIBS VI: El SVB Absorb es Seguro en el Manejo de la Reestenosis Intra-stent pero No Supera al Stent Metálico Xience

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

RIBS VI：Absorb BVS 支架内再狭窄方面安全，但没有好过 Xience 金属支架

TRANSFORM-OCT: 生物可吸收和耐久聚合物 DES 早期和晚期愈合率类似

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

The Tricuspid Valve: Challenges for Clinical Investigation

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened?

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies

Are the Current Clinical Trial Pathways for New Mitral Valve Therapies Practical? A Future Roadmap to Consider!

Mitral Valve Repair vs Replacement: Complementary or Competitive?

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions

Clinical Indications for TAVR: Where are We and Where are We Going?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content